Pollakis G - Search Results

1

Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes.

Stax MJ, van Montfort T, Sprenger RR, Melchers M, Sanders RW, van Leeuwen E, Repping S, Pollakis G, Speijer D, Paxton WA. Stax MJ, et al. Among authors: pollakis g. Virology. 2009 Sep 1;391(2):203-11. doi: 10.1016/j.virol.2009.06.011. Virology. 2009. PMID: 19682628 Free article.

2

A new class of free radical scavengers reducing adriamycin mitochondrial toxicity.

Praet M, Calderon PB, Pollakis G, Roberfroid M, Ruysschaert JM. Praet M, et al. Among authors: pollakis g. Biochem Pharmacol. 1988 Dec 15;37(24):4617-22. doi: 10.1016/0006-2952(88)90329-2. Biochem Pharmacol. 1988. PMID: 2849451

3

Damages of the mitochondrial membrane in Adriamycin treated mice.

Praet M, Pollakis G, Goormaghtigh E, Ruysschaert JM. Praet M, et al. Among authors: pollakis g. Cancer Lett. 1984 Nov;25(1):89-96. doi: 10.1016/s0304-3835(84)80030-0. Cancer Lett. 1984. PMID: 6097353

4

In vivo and in vitro modifications of the mitochondrial membrane induced by 4' Epi-adriamycin.

Praet M, Laghmiche M, Pollakis G, Goormaghtigh E, Ruysschaert JM. Praet M, et al. Among authors: pollakis g. Biochem Pharmacol. 1986 Sep 1;35(17):2923-8. doi: 10.1016/0006-2952(86)90487-9. Biochem Pharmacol. 1986. PMID: 3461789

5

Mitochondrial membrane modifications induced by adriamycin-mediated electron transport.

Goormaghtigh E, Pollakis G, Ruysschaert JM. Goormaghtigh E, et al. Among authors: pollakis g. Biochem Pharmacol. 1983 Mar 1;32(5):889-93. doi: 10.1016/0006-2952(83)90593-2. Biochem Pharmacol. 1983. PMID: 6838634

6

Adriamycin and derivatives interaction with the mitochondrial membrane: O2 consumption and free radicals formation.

Pollakis G, Goormaghtigh E, Delmelle M, Lion Y, Ruysschaert JM. Pollakis G, et al. Res Commun Chem Pathol Pharmacol. 1984 Jun;44(3):445-59. Res Commun Chem Pathol Pharmacol. 1984. PMID: 6463367

7

N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.

Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, Paxton WA. Pollakis G, et al. J Biol Chem. 2001 Apr 20;276(16):13433-41. doi: 10.1074/jbc.M009779200. Epub 2001 Jan 16. J Biol Chem. 2001. PMID: 11278567 Free article.

8

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.

Nabatov AA, Pollakis G, Linnemann T, Kliphius A, Chalaby MI, Paxton WA. Nabatov AA, et al. Among authors: pollakis g. J Virol. 2004 Jan;78(1):524-30. doi: 10.1128/jvi.78.1.524-530.2004. J Virol. 2004. PMID: 14671134 Free PMC article.

9

Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.

Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA. Pollakis G, et al. J Virol. 2004 Mar;78(6):2841-52. doi: 10.1128/jvi.78.6.2841-2852.2004. J Virol. 2004. PMID: 14990703 Free PMC article.

10

Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.

van Opijnen T, Jeeninga RE, Boerlijst MC, Pollakis GP, Zetterberg V, Salminen M, Berkhout B. van Opijnen T, et al. J Virol. 2004 Apr;78(7):3675-83. doi: 10.1128/jvi.78.7.3675-3683.2004. J Virol. 2004. PMID: 15016888 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters